MiR-654-3p Suppresses Non-Small Cell Lung Cancer Tumourigenesis by Inhibiting PLK4

POLQ Overexpression Is Associated with an Increased Somatic Mutation Load and PLK4 Overexpression in Lung Adenocarcinoma

(2019) Kazuya Shinmura et al.   Cancers

FZD10 Carried by Exosomes Sustains Cancer Cell Proliferation

(2019) Scavo et al.   Cells

PLK4: a promising target for cancer therapy

(2019) Yi Zhao et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

miR-342-3p suppresses cell proliferation and migration by targeting AGR2 in non-small cell lung cancer

(2018) Xiaofeng Xue et al.   CANCER LETTERS

MiR-598 Suppresses Invasion and Migration by Negative Regulation of Derlin-1 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer

(2018) Fengming Yang et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Nano-Vesicles are a Potential Tool to Monitor Therapeutic Efficacy of Carbon Ion Radiotherapy in Prostate Cancer

(2018) Qi Yu et al.   Journal of Biomedical Nanotechnology

Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers

(2018) Masanori Kawakami et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Polo-like kinase 4 mediates epithelial–mesenchymal transition in neuroblastoma via PI3K/Akt signaling pathway

(2018) Xiangdong Tian et al.   Cell Death & Disease

Identification of common differentially‑expressed miRNAs in ovarian cancer cells and their exosomes compared with normal ovarian surface epithelial cell cells

(2018) Shitao Zhang et al.   Oncology Letters

MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K/Akt pathway

(2018) Dian-min Sun et al.   Scientific Reports

miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives

(2017) Mateusz Florczuk et al.   Targeted Oncology

Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance

(2017) Chunyu Li et al.   Oncotarget

Immunotherapy for Non-small-cell Lung Cancer: Current Status and Future Obstacles

(2017) Ju Hwan Cho   Immune Network

MicroRNAs in non-small cell lung cancer and idiopathic pulmonary fibrosis

(2016) Keiko Mizuno et al.   JOURNAL OF HUMAN GENETICS

Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer

(2016) Murilo Vieira Geraldo et al.   Oncotarget

Expression of Polo-Like Kinase 4(PLK4) in Breast Cancer and Its Response to Taxane-Based Neoadjuvant Chemotherapy

(2016) Zhenhua Li et al.   Journal of Cancer

Analysis of MicroRNA Expression Profile Identifies Novel Biomarkers for Non-small Cell Lung Cancer

(2015) Chi Xu et al.   TUMORI

Analysis of MicroRNA Expression Profile Identifies Novel Biomarkers for Non-small Cell Lung Cancer

(2015) Chi Xu et al.   TUMORI JOURNAL

BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10

(2014) Chang Gong et al.   Nature Communications

Clinical implication of centrosome amplification and expression of centrosomal functional genes in multiple myeloma

(2013) Elena Dementyeva et al.   Journal of Translational Medicine

MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells

(2013) A Formosa et al.   ONCOGENE

Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

(2012) Julian R. Molina et al.   MAYO CLINIC PROCEEDINGS

Inverse correlation of the up-regulation of FZD10 expression and the activation of β-catenin in synchronous colorectal tumors

(2009) Satoshi Nagayama et al.   CANCER SCIENCE